TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Jul 19, 2016
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Purchase
Common Stock
2016-07-18$4.96/sh+10,000$49,550→ 135,578 total
Holdings
- 54,684(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the weighted average purchase price for the reported transactions. 5,000 of such shares were purchased at $4.95 and 5,000 were purchased at $4.96.
- [F2]The reporting person serves as trustee of the family trust.